Invention Grant
US08383388B2 Modified coagulation factor IX polypeptides and use thereof for treatment
有权
改性凝血因子IX多肽及其用于治疗的用途
- Patent Title: Modified coagulation factor IX polypeptides and use thereof for treatment
- Patent Title (中): 改性凝血因子IX多肽及其用于治疗的用途
-
Application No.: US11818985Application Date: 2007-06-15
-
Publication No.: US08383388B2Publication Date: 2013-02-26
- Inventor: Jorge Oyhenart , Xavier Gallet , Gilles Borrelly , Thierry Guyon , Manuel Vega , Lila Drittanti
- Applicant: Jorge Oyhenart , Xavier Gallet , Gilles Borrelly , Thierry Guyon , Manuel Vega , Lila Drittanti
- Applicant Address: US CA South San Francisco
- Assignee: Catalyst Biosciences, Inc.
- Current Assignee: Catalyst Biosciences, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: McKenna Long & Aldridge LLP
- Agent Stephanie Seidman
- Main IPC: C12N9/64
- IPC: C12N9/64 ; C07K14/00 ; A61K38/48 ; C12P21/00 ; C12Q1/37 ; C12N5/10 ; C12N15/00 ; C12N1/21
Abstract:
Provided are modified factor IX (FIX) polypeptides and methods of generating modified FIX polypeptides. Also provided are pharmaceutical compositions, including compositions formulation for oral administration, that contain the modified FIX polypeptides, and methods of treatment using modified FIX polypeptides.
Public/Granted literature
- US20080102115A1 Modified coagulation factor IX polypeptides and use thereof for treatment Public/Granted day:2008-05-01
Information query
IPC分类:
